Fasken Martineau’s Life Sciences group advises on a wide range of capital raising and mergers and acquisitions (M&A) activities in the life sciences industry. By combining our understanding of applicable securities laws and the life sciences industry with our proven ability to manage large complex transactions, we provide tactical advice that is both sophisticated and innovative.
For emerging private companies, we help in the initial rounds of financing, including guiding them through the investment process of due diligence, refining their governance and capital structure, preparing subscription and offering materials, and negotiating shareholder or other agreements to govern relationships going forward.
For later stage companies, we advise with respect to going public transactions including initial public offerings and reverse take-over listings (including through the TSX-Venture Exchange capital pool program), additional offerings (such as standby equity distribution agreements) and dual listings. Our advice extends to the preparation of prospectuses and filing statements and the clearance of filings with securities regulatory authorities and stock exchange listing committees.
In addition, we advise life sciences clients in their acquisitions and divestments of businesses or products. Our M&A team is experienced in managing complex transactions in the life sciences space, whether friendly or contested. Our clients benefit from a comprehensive deal team comprised of securities, intellectual property, regulatory and tax practitioners in the structuring and negotiation of transactions and transition arrangements.
In addition to our geographical spread across Canada and our established presence in London and Paris, our network of life science specialists in 47 other countries means that we are well placed to handle international and multi-jurisdictional transactions.
Our team works with life sciences companies in all stages of development from early stage to multinational public companies in their capital raising activities and M&A strategies. We advise clients involved in all aspects of a transaction, including acquirers, targets, boards and their special committees, lenders, financial advisors, investors and key shareholders. We also represent some of the leading investment banks in Canada and Europe that operate in the life sciences space.
- Take-over bids
- Corporate finance
- Mergers and acquisitions (M&A)
- Initial public offerings (IPOs) on a range of international exchanges
- Capital reorganizations
- Corporate governance
- Dual listings
- Acquisitions and divestitures
- Contested corporate transactions
- Board and special committee representations
- Start-up enterprises and entrepreneurial development